Novel Soft Dosage Forms for Paediatric Applications: Can We 3D-Print Them or Not?

Author:

Białek Antoni1ORCID,Krysztofiak Julia1ORCID,Hozakowska Aleksandra1,Wojszel Zuzanna1,Osmałek Tomasz2ORCID,Wojtyłko Monika34,Froelich Anna3ORCID

Affiliation:

1. Student’s Research Group of Pharmaceutical Technology, The Student Scientific Society of Poznan University of Medical Sciences, 5 Rokietnicka Street, 60-806 Poznań, Poland

2. Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland

3. Chair and Department of Pharmaceutical Technology, 3D Printing Division, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznań, Poland

4. Doctoral School, Poznan University of Medical Sciences, 70 Bukowska Street, 60-812 Poznań, Poland

Abstract

Over the past years, numerous novel dosage forms, including gels, have been investigated for paediatric treatment due to the need to provide flexible dose adjustment possibilities, as well as a patient-friendly approach to drug delivery. Simultaneously, 3D printing technology is continuously advancing and gaining interest as a tool for personalised formulation development. Multiple additive manufacturing methods, including the semi-solid extrusion, especially used in gel printing, provide flexibility regarding the dose of active ingredients and the adjustment of the design of soft dosage forms. 3D printing techniques can be considered as a possible answer to the demand for medicines tailored to small patients’ needs. This review intends to present an overview of the current possibilities, comparing gel-like and non-gel-formulated dosage forms and crucial aspects of developing those cutting-edge dosage forms by 3D printing. This paper discusses soft formulations such as chewing gums, which still require extensive evaluation, and explores the question of the three-dimensional printing process. Furthermore, it highlights soft dosage forms, such as gel-based gummies and hydrogels, for which 3D fabrication has been intensively studied in previous years. However, the research still needs to advance.

Funder

National Science Centre

Publisher

MDPI AG

Reference180 articles.

1. (2025, January 10). Integrated Management of Childhood Illness (WHO). Available online: https://www.who.int/teams/maternal-newborn-child-adolescent-health-and-ageing/child-health/integrated-management-of-childhood-illness.

2. Pediatric Formulation Development–Challenges of Today and Strategies for Tomorrow: Summary Report from M−CERSI Workshop 2019;Tan;Eur. J. Pharm. Biopharm.,2021

3. From Paediatric Formulations Development to Access: Advances Made and Remaining Challenges;Litalien;Brit J. Clin. Pharma,2022

4. The Development of Medicines for Children;Rocchi;Pharmacol. Res.,2011

5. How Close Is the Dose? Manipulation of 10 Mg Hydrocortisone Tablets to Provide Appropriate Doses to Children;Watson;Int. J. Pharm.,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3